Related Experiment Video
Updated: Jun 29, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program
Sunita Sharma1, Augusto A Litonjua, Kelan G Tantisira
1Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. ssharma4@partners.org
Insights
Children with consistent bronchodilator response (BDR) to asthma medications over time often have poorer outcomes. Predictors include lower lung function and higher IgE levels, indicating a need for closer monitoring.
Area of Science:
- Pediatric Pulmonology
- Asthma Phenotyping
- Clinical Outcomes Research
Background:
- Bronchodilator response (BDR) to beta(2)-agonists in asthma is variable.
- The long-term significance of a consistent BDR is not well understood.
Purpose of the Study:
- To identify baseline clinical predictors of a consistent BDR over 4 years in children with mild-to-moderate persistent asthma.
- To determine the clinical outcomes associated with a consistent BDR phenotype.
Main Methods:
- Analysis of 1041 children from the Childhood Asthma Management Program.
- Defined consistent BDR as a >=12% and >=200 mL FEV(1) increase after beta(2)-agonist at yearly visits.
- Compared clinical outcomes between children with and without consistent BDR.
Main Results:
- Identified 52 children with consistent BDRs over 4 years.
- Consistent BDR associated with lower baseline FEV(1), higher IgE, and no inhaled corticosteroid use.
- Consistent BDR linked to increased hospital visits, prednisone use, nocturnal awakenings, and missed school days.
Conclusions:
- Identified key predictors for a consistent bronchodilator response phenotype in pediatric asthma.
- Demonstrated that a consistent BDR is associated with significantly worse asthma-related clinical outcomes.
Background:
Among asthmatic subjects, bronchodilator response (BDR) to inhaled beta(2)-adrenergic agonists is variable, and the significance of a consistent response over time is unknown.
Objective:
We assessed baseline clinical variables and determined the clinical outcomes associated with a consistently positive BDR over 4 years in children with mild-to-moderate persistent asthma.
Methods:
In the 1041 participants in the Childhood Asthma Management Program, subjects with a change in FEV(1) of 12% or greater (and 200 mL) after inhaled beta(2)-agonist administration at each of their yearly follow-up visits (consistent BDR) were compared with those who did not have a consistent BDR.
Results:
We identified 52 children with consistent BDRs over the 4-year trial. Multivariable logistic regression modeling demonstrated that lower baseline prebronchodilator FEV(1) values (odds ratio, 0.71; P < .0001), higher log10 IgE levels (odds ratio, 1.97; P = .002), and lack of treatment with inhaled corticosteroids (odds ratio, 0.31; P = .009) were associated with a consistent BDR. Individuals who had a consistent BDR had more hospital visits (P = .007), required more prednisone bursts (P = .0007), had increased nocturnal awakenings caused by asthma (P < .0001), and missed more days of school (P = .03) than nonresponders during the 4-year follow-up.
Conclusions:
We have identified predictors of consistent BDR and determined that this phenotype is associated with poor clinical outcomes.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Asthma-IV: Nursing Management
First, in...
Asthma III: Clinical Manifestations